Изменение пролактина на фоне приема современных оральных контрацептивов у девушек с функциональной гиперпролактинемией

Лабыгина Альбина Владимировна, Л. В. Сутурина, О. Я. Лещенко et al. · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · 2006

The paper presents results of hormonal screening performed in 220 young girls (aged 21,65 ±2,1 yrs) before and in 3 months after intake of combined oral contraceptives (COC). The normal level of prolactin (PRL) was determined in 168 women (76,4 %) that entered the control group (2), in 44 women (20 %) there was registered elevated level of PRL they entered the study group (1). In 8 girls (3,6 %) PRL was higher than 1500 mlU/ml and in 5 of these subjects there was diagnosed pituitary microadenoma after NMR examination that made us exclude them from the study. Thus there was registered high freguency of hyperprolactinemia (23,6 %) in girls that plan to take COC. Against a background of COC intake we marked decrease of PRL-level in the most of subjects with hyperprolactinemia (90 %) but in 10 % we observed further elevation of PRL-level that needs more accurate doctor's control taking into account the high level of chronic somatic and endocrine pathology in this patients' group. We consider that it is advisable to control PRL-level in dynamics in girls taking COC.

Cited by 0 works.

Authors